Torrent Pharma, the flagship Company of Torrent Group is one of the leading pharma companies of the Country.
The Company was a pioneer in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.
The company was founded in 1959 and the headquarter was established in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals operates in more than 40 countries with over 2000 product registrations globally.Torent Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.
The company’s key areas are Formulations, API, Drug Discovery, Marketing and Sales of Drugs.
Torrent’s Manufacturing Plants:
▪️Manufacturing plant at Dahej, Gujarat
▪️Manufacturing plant at Pithampur, Madhya Pradesh
▪️Manufacturing plant at Indrad, Mehsana, Gujarat
▪️Manufacturing plant at Baddi, Himachal Pradesh
▪️3 Manufacturing plant at Rang-Po,(Sikkim)
▪️Research Centre, Ahmedabad-Gandhinagar region, Gujarat
▪️Corporate Office, beside sales India, off. Ashram Road, [Ahmedabad]- Gujarat
▪️Manufacturing plant at Visakhapatnam (Andhra Pradesh)
Torrent Pharmaceuticals Ltd has acquired US-based generic pharmaceuticals company Bio-Pharm for an undisclosed amount, the company said in a stock-exchange disclosure.
The acquisition will help Torrent Pharma diversify its dosage form, expand its presence in the US and will provide it with manufacturing and R&D capabilities in that country, the company added.
In 2016 Torrent Pharmaceuticals’ Dahej plant received USFDA approval. The pharma company’s most recent acquisition was in November 2017, when it acquired the branded formulations business of Unichem Laboratories Ltd in India and Nepal for Rs 3,600 crore. Prior to that, it bought a portfolio of brands from Novartis India in March 2017.
In June 2016, it bought an active pharmaceutical ingredient facility of Hyderabad-based Glochem Industries Ltd for an undisclosed amount.
In 2015, it acquired Zyg Pharma, which manufactures various dermatological formulations like creams, ointments, gels, lotions and solutions, for an undisclosed amount.
Torrent Pharma has crossed many geographical boundaries with presence in more than 40 countries. The Company is ranked first amongst Indian Companies for having largest market share in Brazil and Germany.